Neuraxpharm, Provigil®

Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil®

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Neuraxpharm United States of America United Kingdom Germany Spain

View original content:https://www.prnewswire.co.uk/news-releases/neuraxpharm-to-further-grow-branded-business-with-the-acquisition-of-two-leading-narcolepsy-treatments-provigil-and-nuvigil-302343298.html

en | boerse | 67978499 |